Baidu
map

Results of a multicenter phase I/II trial of TCR alpha beta and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

Bethge, WA; Eyrich, M; Mielke, S; Meisel, R; Niederwieser, D; Schlegel, PG; Schulz, A; Greil, J; Bunjes, D; Brecht, A; Kuball, J; Schumm, M; Vucinic, V; Wiesneth, M; Bonig, H; Westinga, K; Biedermann, S; Holtkamp, S; Karitzky, S; Malchow, M; Siewert, C; Handgretinger, R; Lang, P

Bethge, WA (通讯作者),Univ Hosp Tuebingen, Ctr Internal Med, Dept Hematol Oncol Clin Immunol & Rheumatol, Tubingen, Germany.;Lang, P (通讯作者),Univ Childrens Hosp Tuebingen, Dept Hematol Oncol, Tubingen, Germany.

BONE MARROW TRANSPLANTATION, 2022; 57 (3): 423

Abstract

Hematopoietic stem cell transplantation (HSCT) from haploidentical donors is a viable option for patients lacking HLA-matched donors. Here we report t......

Full Text Link


Baidu
map
Baidu
map
Baidu
map